Purpose: Diabetes mellitus (DM) is associated with elevated cancer risk and poor survival outcome in malignancies. The objective of this study was to evaluate the prognostic value of preexisting DM in chronic lymphocytic leukemia (CLL).
Materials And Methods: Six hundred and thirty-three subjects with newly-diagnosed CLL between 2007 and 2016 were recruited.
Diabetes mellitus (DM) is associated with elevated cancer risk and poor survival. The objective of this study was to assess the prognostic value of DM in diffuse large B-cell lymphoma (DLBCL). Five hundred and fifty-three newly diagnosed DLBCL patients whose treatments included rituximab were recruited.
View Article and Find Full Text PDF